Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis

Kevin N. Sorensen, Raymond A. Sobel, Karl V. Clemons, Demosthenes Pappagianis, David A. Stevens, Paul L. Williams

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Coccidioidal meningitis is a devastating disease that requires long-term therapy with little hope of cure. A rabbit model of coccidioidal meningitis was used to compare the therapeutic efficacies of fluconazole (FCZ) and itraconazole (ITZ). Hydrocortisone-treated male New Zealand white rabbits were infected intracisternally with 5.0 x 104 to 5.4 x 104 arthroconidia of Coccidioides immitis. Oral treatment with polyethylene glycol 200 (PEG) (n = 9), FCZ (n = 8; 80 mg/kg of body weight/day), or ITZ (n = 8; 80 mg/kg/day) began 5 days after infection and continued for 28 consecutive days. Both FCZ and ITZ reduced the number of CFU of C. immitis organisms in the spinal cord and brain compared with the number in PEG-treated animals (P ≤ 0.003), but the results for FCZ and ITZ were not different from each other. Histopathologic severity (semiquantitative scoring system by an observer blinded to treatment) was equally reduced in both FCZ and ITZ treatment groups compared with that in controls (P ≤ 0.0004). Both treatments resulted in lower cerebrospinal fluid (CSF) protein concentrations and leukocyte counts and faster clearing of C. immitis from CSF compared with the results for PEG-treated controls. Neither drug affected CSF glucose levels. Both compounds were effective at reducing neurological and systemic signs and extending survival (P ≤ 0.014). FCZ was more effective at reducing head and body shakes, posture changes, and incontinence; ITZ was more effective at reducing continuous fever. Mean levels of FCZ and ITZ in the serum and CSF were determined by bioassay; at 17 to 26 h postdosing, levels were 28.1 to 40.0 and 22.4 to 29.9 μg/ml, respectively, for FCZ and 0.77 to 2.51 and 0 μg/ml, respectively, for ITZ. The sera of most animals developed antibody to C. immitis, but azole treatment attenuated antibody development in CSF and its titer. In conclusion, both FCZ and ITZ were efficacious, but neither was curative in a rabbit model of coccidioidal meningitis.

Original languageEnglish (US)
Pages (from-to)1512-1517
Number of pages6
JournalAntimicrobial Agents and Chemotherapy
Volume44
Issue number6
DOIs
StatePublished - 2000

Fingerprint

Itraconazole
Fluconazole
Meningitis
Rabbits
Coccidioides
Cerebrospinal Fluid
Cerebrospinal Fluid Proteins
Azoles
Antibodies
Serum
Posture
Leukocyte Count
Biological Assay
Hydrocortisone
Spinal Cord
Fever
Head
Body Weight
Glucose
Brain

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis. / Sorensen, Kevin N.; Sobel, Raymond A.; Clemons, Karl V.; Pappagianis, Demosthenes; Stevens, David A.; Williams, Paul L.

In: Antimicrobial Agents and Chemotherapy, Vol. 44, No. 6, 2000, p. 1512-1517.

Research output: Contribution to journalArticle

Sorensen, Kevin N. ; Sobel, Raymond A. ; Clemons, Karl V. ; Pappagianis, Demosthenes ; Stevens, David A. ; Williams, Paul L. / Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis. In: Antimicrobial Agents and Chemotherapy. 2000 ; Vol. 44, No. 6. pp. 1512-1517.
@article{690d7aceb8f541e28fbe43a137d94617,
title = "Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis",
abstract = "Coccidioidal meningitis is a devastating disease that requires long-term therapy with little hope of cure. A rabbit model of coccidioidal meningitis was used to compare the therapeutic efficacies of fluconazole (FCZ) and itraconazole (ITZ). Hydrocortisone-treated male New Zealand white rabbits were infected intracisternally with 5.0 x 104 to 5.4 x 104 arthroconidia of Coccidioides immitis. Oral treatment with polyethylene glycol 200 (PEG) (n = 9), FCZ (n = 8; 80 mg/kg of body weight/day), or ITZ (n = 8; 80 mg/kg/day) began 5 days after infection and continued for 28 consecutive days. Both FCZ and ITZ reduced the number of CFU of C. immitis organisms in the spinal cord and brain compared with the number in PEG-treated animals (P ≤ 0.003), but the results for FCZ and ITZ were not different from each other. Histopathologic severity (semiquantitative scoring system by an observer blinded to treatment) was equally reduced in both FCZ and ITZ treatment groups compared with that in controls (P ≤ 0.0004). Both treatments resulted in lower cerebrospinal fluid (CSF) protein concentrations and leukocyte counts and faster clearing of C. immitis from CSF compared with the results for PEG-treated controls. Neither drug affected CSF glucose levels. Both compounds were effective at reducing neurological and systemic signs and extending survival (P ≤ 0.014). FCZ was more effective at reducing head and body shakes, posture changes, and incontinence; ITZ was more effective at reducing continuous fever. Mean levels of FCZ and ITZ in the serum and CSF were determined by bioassay; at 17 to 26 h postdosing, levels were 28.1 to 40.0 and 22.4 to 29.9 μg/ml, respectively, for FCZ and 0.77 to 2.51 and 0 μg/ml, respectively, for ITZ. The sera of most animals developed antibody to C. immitis, but azole treatment attenuated antibody development in CSF and its titer. In conclusion, both FCZ and ITZ were efficacious, but neither was curative in a rabbit model of coccidioidal meningitis.",
author = "Sorensen, {Kevin N.} and Sobel, {Raymond A.} and Clemons, {Karl V.} and Demosthenes Pappagianis and Stevens, {David A.} and Williams, {Paul L.}",
year = "2000",
doi = "10.1128/AAC.44.6.1512-1517.2000",
language = "English (US)",
volume = "44",
pages = "1512--1517",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "6",

}

TY - JOUR

T1 - Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis

AU - Sorensen, Kevin N.

AU - Sobel, Raymond A.

AU - Clemons, Karl V.

AU - Pappagianis, Demosthenes

AU - Stevens, David A.

AU - Williams, Paul L.

PY - 2000

Y1 - 2000

N2 - Coccidioidal meningitis is a devastating disease that requires long-term therapy with little hope of cure. A rabbit model of coccidioidal meningitis was used to compare the therapeutic efficacies of fluconazole (FCZ) and itraconazole (ITZ). Hydrocortisone-treated male New Zealand white rabbits were infected intracisternally with 5.0 x 104 to 5.4 x 104 arthroconidia of Coccidioides immitis. Oral treatment with polyethylene glycol 200 (PEG) (n = 9), FCZ (n = 8; 80 mg/kg of body weight/day), or ITZ (n = 8; 80 mg/kg/day) began 5 days after infection and continued for 28 consecutive days. Both FCZ and ITZ reduced the number of CFU of C. immitis organisms in the spinal cord and brain compared with the number in PEG-treated animals (P ≤ 0.003), but the results for FCZ and ITZ were not different from each other. Histopathologic severity (semiquantitative scoring system by an observer blinded to treatment) was equally reduced in both FCZ and ITZ treatment groups compared with that in controls (P ≤ 0.0004). Both treatments resulted in lower cerebrospinal fluid (CSF) protein concentrations and leukocyte counts and faster clearing of C. immitis from CSF compared with the results for PEG-treated controls. Neither drug affected CSF glucose levels. Both compounds were effective at reducing neurological and systemic signs and extending survival (P ≤ 0.014). FCZ was more effective at reducing head and body shakes, posture changes, and incontinence; ITZ was more effective at reducing continuous fever. Mean levels of FCZ and ITZ in the serum and CSF were determined by bioassay; at 17 to 26 h postdosing, levels were 28.1 to 40.0 and 22.4 to 29.9 μg/ml, respectively, for FCZ and 0.77 to 2.51 and 0 μg/ml, respectively, for ITZ. The sera of most animals developed antibody to C. immitis, but azole treatment attenuated antibody development in CSF and its titer. In conclusion, both FCZ and ITZ were efficacious, but neither was curative in a rabbit model of coccidioidal meningitis.

AB - Coccidioidal meningitis is a devastating disease that requires long-term therapy with little hope of cure. A rabbit model of coccidioidal meningitis was used to compare the therapeutic efficacies of fluconazole (FCZ) and itraconazole (ITZ). Hydrocortisone-treated male New Zealand white rabbits were infected intracisternally with 5.0 x 104 to 5.4 x 104 arthroconidia of Coccidioides immitis. Oral treatment with polyethylene glycol 200 (PEG) (n = 9), FCZ (n = 8; 80 mg/kg of body weight/day), or ITZ (n = 8; 80 mg/kg/day) began 5 days after infection and continued for 28 consecutive days. Both FCZ and ITZ reduced the number of CFU of C. immitis organisms in the spinal cord and brain compared with the number in PEG-treated animals (P ≤ 0.003), but the results for FCZ and ITZ were not different from each other. Histopathologic severity (semiquantitative scoring system by an observer blinded to treatment) was equally reduced in both FCZ and ITZ treatment groups compared with that in controls (P ≤ 0.0004). Both treatments resulted in lower cerebrospinal fluid (CSF) protein concentrations and leukocyte counts and faster clearing of C. immitis from CSF compared with the results for PEG-treated controls. Neither drug affected CSF glucose levels. Both compounds were effective at reducing neurological and systemic signs and extending survival (P ≤ 0.014). FCZ was more effective at reducing head and body shakes, posture changes, and incontinence; ITZ was more effective at reducing continuous fever. Mean levels of FCZ and ITZ in the serum and CSF were determined by bioassay; at 17 to 26 h postdosing, levels were 28.1 to 40.0 and 22.4 to 29.9 μg/ml, respectively, for FCZ and 0.77 to 2.51 and 0 μg/ml, respectively, for ITZ. The sera of most animals developed antibody to C. immitis, but azole treatment attenuated antibody development in CSF and its titer. In conclusion, both FCZ and ITZ were efficacious, but neither was curative in a rabbit model of coccidioidal meningitis.

UR - http://www.scopus.com/inward/record.url?scp=0034036544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034036544&partnerID=8YFLogxK

U2 - 10.1128/AAC.44.6.1512-1517.2000

DO - 10.1128/AAC.44.6.1512-1517.2000

M3 - Article

C2 - 10817701

AN - SCOPUS:0034036544

VL - 44

SP - 1512

EP - 1517

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 6

ER -